Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Greatbatch Inc Reaffirms FY 2013 Guidance


Thursday, 25 Apr 2013 04:05pm EDT 

Greatbatch Inc reaffirmed adjusted operating income as a percentage of sales and adjusted diluted EPS guidance ranges provided at the beginning of fiscal 2013. The Company expects adjusted operating income as a % of sales 12.0%-12.5%, adjusted Diluted EPS $1.90-$2.00. Based on the actual results for the first quarter and current expectations for the remainder of the year, it sees a general trend towards the lower end of original sales guidance of $660 million to $680 million provided at the beginning of the year. If achieved, this would result in organic revenue growth of 5%-8% due to the disposition of $15 million of non-core orthopaedic product lines at the end of 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $669 million and EPS of $1.95 for fiscal 2013. 

Company Quote

45.59
0.52 +1.15%
15 Sep 2014